glp-1 gallstones Gallbladder Risk: What Clinicians Should Watch Reconciling GLP-1s and Pancreatitis

In India, you typically qualify if: Your BMI is 30 or above (obesity), or Your BMI is 27.5 or above with a condition like prediabetes, PCOS, or fatty liver These medicines are not for cosmetic weight loss

This reduced hunger can help lower your calorie intake, especially when combined with a healthy meal plan and increased physical activityboth of which our team can help you develop

MBX 4291, dual GLP-1/GIP co-agonist prodrug designed for potential once-monthly dosing and improved tolerability in obesity Recent Highlights: In June 2026, MBX Biosciences announced data that demonstrated sustained benefit of its once-weekly Canvuparatide as a potential PTH replacement therapy in chronic hypoparathyroidism

This is especially important when daily GLP-1 regimens face a high risk of discontinuation within just 120 days